152 related articles for article (PubMed ID: 9634459)
1. Outcome of residual mediastinal masses of thoracic lymphomas in children: impact on management and radiological follow-up strategy.
Brisse H; Pacquement H; Burdairon E; Plancher C; Neuenschwander S
Pediatr Radiol; 1998 Jun; 28(6):444-50. PubMed ID: 9634459
[TBL] [Abstract][Full Text] [Related]
2. [Radiological features of thoracic localizations of lymphomas].
Essadki O; el Wady N; el Abassi Skalli A; Harif M; Benchekroun S; Benchemsi N; Kadiri R
Bull Cancer; 1996 Nov; 83(11):929-36. PubMed ID: 9033603
[TBL] [Abstract][Full Text] [Related]
3. 18-FDG-PET for the assessment of residual masses on CT following treatment of lymphomas.
Mikhaeel NG; Timothy AR; Hain SF; O'Doherty MJ
Ann Oncol; 2000; 11 Suppl 1():147-50. PubMed ID: 10707798
[TBL] [Abstract][Full Text] [Related]
4. Value of sonography in monitoring the therapeutic response of mediastinal lymphoma: comparison with chest radiography and CT.
Wernecke K; Vassallo P; Hoffmann G; Peters PE; Poetter R; Rummeny E; Koch P
AJR Am J Roentgenol; 1991 Feb; 156(2):265-72. PubMed ID: 1898797
[TBL] [Abstract][Full Text] [Related]
5. [Computerized tomography in the staging and the follow-up of Hodgkin's lymphoma of the thorax].
Garribba AP; Ettorre GC; Francioso G; Villani PC; Angone G; Liso V; Specchia G; Pavone V; Capalbo S
Radiol Med; 1990 Dec; 80(6):859-64. PubMed ID: 2281167
[TBL] [Abstract][Full Text] [Related]
6. Thoracic CT-scanning follow-up of residual mediastinal masses after treatment of Hodgkin's disease.
Thomas F; Cosset JM; Cherel P; Renaudy N; Carde P; Piekarski JD
Radiother Oncol; 1988 Feb; 11(2):119-22. PubMed ID: 3353516
[TBL] [Abstract][Full Text] [Related]
7. Are 18fluorodeoxyglucose positron emission tomography and magnetic resonance imaging useful in the prediction of relapse in lymphoma residual masses?
Maisey NR; Hill ME; Webb A; Cunningham D; Flux GD; Padhani A; Ott RJ; Norman A; Bishop L
Eur J Cancer; 2000 Jan; 36(2):200-6. PubMed ID: 10741278
[TBL] [Abstract][Full Text] [Related]
8. Gallium scan in the evaluation of post chemotherapy mediastinal residual masses of aggressive non-Hodgkin's lymphoma.
Ulusakarya A; Lumbroso J; Casiraghi O; Koscielny S; Vantelon JM; Girinsky T; Tardivon A; Bourhis JH; Dartevelle P; Pico JL; Munck JN
Leuk Lymphoma; 1999 Nov; 35(5-6):579-86. PubMed ID: 10609795
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of residual mediastinal-hilar Ga-67 uptake after treatment for Hodgkin's and non-Hodgkin's lymphomas: what degree of Ga-67 uptake is significant?
Nikpoor N; Aliabadi P; Diaz L; Mannting F
Clin Nucl Med; 2000 Dec; 25(12):959-62. PubMed ID: 11129161
[TBL] [Abstract][Full Text] [Related]
10. Mediastinal Hodgkin disease in children: response to therapy.
Luker GD; Siegel MJ
Radiology; 1993 Dec; 189(3):737-40. PubMed ID: 8234698
[TBL] [Abstract][Full Text] [Related]
11. [Clinical x-ray comparisons in the intrathoracic localization of lymphogranulomatosis and non-Hodgkin lymphomas].
Simbirtseva LP; Shedakov AA; Shust VF; Davydova SB
Vopr Onkol; 1986; 32(1):50-5. PubMed ID: 3753812
[TBL] [Abstract][Full Text] [Related]
12. Comparison of CT and chest radiographs in the evaluation of post-therapy lymphoma patients.
Khan A; Herman PG; Jojas KA; Nuskind R; Jagathambal K
Eur J Radiol; 1989 May; 9(2):96-100. PubMed ID: 2743988
[TBL] [Abstract][Full Text] [Related]
13. [Diagnostic value of ultrasonographic evaluation of thoracic and cervical organs in lymphogranulomatosis and lymphosarcoma].
Kharchenko VP; Gurevich LA; Panśhin GA; Litvakovskaia NB; Dotsenko PV
Vestn Rentgenol Radiol; 1994; (3):12-8. PubMed ID: 7985365
[TBL] [Abstract][Full Text] [Related]
14. Follow-up of mediastinal lymphoma: role of ultrasonography.
De Pascale A; Giorcelli R; Garofalo G; Perotto F; Parvis G; Gino M; Fava C
Radiol Med; 2006 Sep; 111(6):759-72. PubMed ID: 16896564
[TBL] [Abstract][Full Text] [Related]
15. [Does residual mediastinal mass in children with completed treatment of Hodgkin's disease affect the incidence of relapses?].
Balwierz W; Armata J; Moryl-Bujakowska A; Depowska T; Bogusławska-Jaworska J; Pisarek J; Sońta-Jakimczyk D; Janik-Moszant A; Rokicka-Milewska R; Sopyło B; Kołakowska-Mrozowska B; Radwańska U; Kołecki P; Kaczmarek-Kanold M; Kowalczyk J; Skomra S; Ochocka M; Matysiak M; Newecka-Samól T
Wiad Lek; 1998; 51 Suppl 4():12-7. PubMed ID: 10731938
[TBL] [Abstract][Full Text] [Related]
16. Thoracic lymphoma.
North LB; Libshitz HI; Lorigan JG
Radiol Clin North Am; 1990 Jul; 28(4):745-62. PubMed ID: 2190268
[TBL] [Abstract][Full Text] [Related]
17. Hodgkin disease and non-Hodgkin lymphoma: plain chest radiographs and chest computed tomography of thoracic involvement in previously untreated patients.
Romano M; Libshitz HI
Radiol Med; 1998; 95(1-2):49-53. PubMed ID: 9636727
[TBL] [Abstract][Full Text] [Related]
18. Assessment of residual posttreatment masses in Hodgkin's disease and the need for biopsy in children.
Nasr A; Stulberg J; Weitzman S; Gerstle JT
J Pediatr Surg; 2006 May; 41(5):972-4. PubMed ID: 16677895
[TBL] [Abstract][Full Text] [Related]
19. Residual masses on follow-up computed tomography in patients with mediastinal non-Hodgkin's lymphoma.
Uematsu M; Kondo M; Tsutsui T; Murase T; Yorozu A; Hiramatsu H; Fujii H; Hashimoto S
Clin Radiol; 1989 May; 40(3):244-7. PubMed ID: 2752680
[TBL] [Abstract][Full Text] [Related]
20. The significance of a residual mediastinal mass following treatment for aggressive non-Hodgkin's lymphomas.
Tredaniel J; Brice P; Lepage E; Bris C; Marolleau JP; Ferme C; Hennequin C; Fermand JP; Frija J; Gisselbrecht C
Eur Respir J; 1992 Feb; 5(2):170-3. PubMed ID: 1559581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
